Alias
科研级 Racotumomab ( 雷妥莫单抗 ), Anti-Idiotope of Anti-(NGNA-Gangliosides GM3) Mouse P3 IgM-kappa Monoclonal Antibody Recombinant Antibody, Research Grade Racotumomab
Molecular Name
Racotumomab
Applications
FC, IP, ELISA, Neut, FuncS, IF
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
Idiotope of anti-(N-glycolylneuraminic acid (NeuGc,NGNA) -gangliosides GM3) Mus musculus IgM-kappa monoclonal antibody P3[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors that is currently under clinical development by Recombio, an international public-private consortium with the participation of the Center of Molecular Immunology at Havana, Cuba (CIM) and researchers from Buenos Aires University and National University of Quilmes in Argentina.
Storage
该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。